mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |